Search

Search Constraints

You searched for: Author/Creator Bentz, Martin

Search Results

1. AFM13 in patients with relapsed or refractory classical Hodgkin lymphoma: final results of an open-label, randomized, multicenter phase II trial. Issue 8 (3rd July 2022)

2. High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial. Issue 8 (August 2016)

3. Histopathological changes resulting from selective internal radiotherapy (SIRT). Issue 5 (15th February 2018)

4. Liver resection after selective internal radiotherapy (SIRT): Proof of concept, initial survival, and safety. Issue 4 (8th August 2015)

5. Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial. Issue 9976 (11th April 2015)

6. PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial. Issue 6 (June 2021)

7. PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group. Issue 10114 (23rd December 2017)

8. Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial. (29th September 2017)

9. Preinfection laboratory parameters may predict COVID‐19 severity in tumor patients. (13th June 2021)

10. Renaissance of Radiotherapy in Intestinal Lymphoma? 10‐Year Efficacy and Tolerance in Multimodal Treatment of 134 Patients: Follow‐up of Two German Multicenter Consecutive Prospective Phase II Trials. (27th March 2020)